The Moving Average Convergence Divergence (MACD) for ANIP turned positive on October 19, 2026. Looking at past instances where ANIP's MACD turned positive, the stock continued to rise in 44 of 58 cases over the following month. The odds of a continued upward trend are 76%.
Following a +2.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in 212 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 59 cases where ANIP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIP as a result. In 59 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
ANIP moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for ANIP entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.769) is normal, around the industry mean (8.329). P/E Ratio (14.907) is within average values for comparable stocks, (-1.568). Projected Growth (PEG Ratio) (1.856) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (1.657) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. ANIP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Moving Average Convergence Divergence (MACD) for INDV turned positive on October 26, 2026. Looking at past instances where INDV's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INDV's RSI Indicator exited the oversold zone, 24 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 62 cases where INDV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on INDV as a result. In 70 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
INDV moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where INDV advanced for three days, in 138 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
INDV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 50-day moving average for INDV moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for INDV entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-20.168) is normal, around the industry mean (8.329). P/E Ratio (12.281) is within average values for comparable stocks, (-1.568). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (2.152). Dividend Yield (0.054) settles around the average of (0.044) among similar stocks. P/S Ratio (3.330) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. INDV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ANIP | INDV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 39 | 40 | |
SMR RATING 1..100 | 48 | 64 | |
PRICE GROWTH RATING 1..100 | 69 | 56 | |
P/E GROWTH RATING 1..100 | 95 | 93 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INDV's Valuation (5) in the null industry is somewhat better than the same rating for ANIP (69) in the Pharmaceuticals Other industry. This means that INDV’s stock grew somewhat faster than ANIP’s over the last 12 months.
ANIP's Profit vs Risk Rating (39) in the Pharmaceuticals Other industry is in the same range as INDV (40) in the null industry. This means that ANIP’s stock grew similarly to INDV’s over the last 12 months.
ANIP's SMR Rating (48) in the Pharmaceuticals Other industry is in the same range as INDV (64) in the null industry. This means that ANIP’s stock grew similarly to INDV’s over the last 12 months.
INDV's Price Growth Rating (56) in the null industry is in the same range as ANIP (69) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to ANIP’s over the last 12 months.
INDV's P/E Growth Rating (93) in the null industry is in the same range as ANIP (95) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to ANIP’s over the last 12 months.
| ANIP | INDV | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 75% |
| Stochastic ODDS (%) | 3 days ago 68% | 3 days ago 68% |
| Momentum ODDS (%) | 3 days ago 66% | 3 days ago 77% |
| MACD ODDS (%) | 3 days ago 76% | 3 days ago 79% |
| TrendWeek ODDS (%) | 3 days ago 69% | 3 days ago 71% |
| TrendMonth ODDS (%) | 3 days ago 69% | 3 days ago 68% |
| Advances ODDS (%) | 4 days ago 71% | 3 days ago 67% |
| Declines ODDS (%) | 6 days ago 70% | 17 days ago 71% |
| BollingerBands ODDS (%) | N/A | 3 days ago 78% |
| Aroon ODDS (%) | 3 days ago 73% | 3 days ago 67% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANIP’s FA Score shows that 0 FA rating(s) are green while INDV’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANIP’s TA Score shows that 2 TA indicator(s) are bullish while INDV’s TA Score has 7 bullish TA indicator(s).
ANIP (@Pharmaceuticals: Generic) experienced а -0.84% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +2.61% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.14%. For the same industry, the average monthly price growth was -9.43%, and the average quarterly price growth was +3.28%.
ANIP is expected to report earnings on Nov 05, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then AMRX could also see price increases.
| Ticker / NAME | Correlation To ANIP | 1D Price Change % | ||
|---|---|---|---|---|
| ANIP | 100% | -1.59% | ||
| AMRX - ANIP | 39% Loosely correlated | +0.75% | ||
| AMPH - ANIP | 33% Loosely correlated | +2.93% | ||
| SUPN - ANIP | 33% Loosely correlated | +0.19% | ||
| COLL - ANIP | 32% Poorly correlated | -0.96% | ||
| SNDL - ANIP | 31% Poorly correlated | -4.62% | ||
More | ||||
A.I.dvisor indicates that over the last year, INDV has been loosely correlated with SUPN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INDV jumps, then SUPN could also see price increases.
| Ticker / NAME | Correlation To INDV | 1D Price Change % | ||
|---|---|---|---|---|
| INDV | 100% | +0.34% | ||
| SUPN - INDV | 42% Loosely correlated | +0.19% | ||
| EBS - INDV | 31% Poorly correlated | -5.68% | ||
| AMRX - INDV | 31% Poorly correlated | +0.75% | ||
| XERS - INDV | 27% Poorly correlated | -0.37% | ||
| ANIP - INDV | 27% Poorly correlated | -1.59% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLIN | 34.05 | 0.16 | +0.47% |
| Franklin FTSE India ETF (FLIN) | |||
| LALT | 24.78 | -0.07 | -0.28% |
| First Trust Multi-Strategy Alternative ETF (LALT) | |||
| WEA | 9.68 | -0.06 | -0.62% |
| Western Asset Premier | |||
| GENW | 14.59 | -0.10 | -0.67% |
| Genter Capital International Dividend ETF (GENW) | |||
| WCME | 17.48 | -0.39 | -2.18% |
| First Trust WCM Developing World Equity ETF (WCME) | |||